US launches Germany pharma pricing probe, raising threat of new tariffs
Key takeaways
- Germany came under fresh US trade scrutiny on Thursday as the United States launched an investigation into the country's pharmaceutical pricing policies, a move that could pave the way for new tariffs.
- Issued on: 19/06/2026 - 05:10Modified: 19/06/2026 - 05:13
- A federal register notice released by the USTR charged that "evidence indicates that Germany implements unfair pricing policies and practices with regard to innovative pharmaceutical products."
Why this matters: an international story with cross-border implications worth tracking.
Germany came under fresh US trade scrutiny on Thursday as the United States launched an investigation into the country's pharmaceutical pricing policies, a move that could pave the way for new tariffs. Washington said it would examine whether Germany's pricing practices unfairly underpay for innovative medicines and burden US commerce under Section 301 trade authorities.
Issued on: 19/06/2026 - 05:10Modified: 19/06/2026 - 05:13
By: FRANCE 24 Pharmaceuticals are seen in North Andover, Mass., on June 15, 2018 © Elise Amendola, AP The United States on Thursday started an investigation into Germany over its pharmaceutical pricing policies and other practices, in a move that could lead to fresh tariffs.